Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent
about
Adoptive immunotherapy for cancer: building on successProducer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumorsTh2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma.High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporationPrimary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine.Clinical and immunologic basis of interferon therapy in melanoma.Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses.Cutaneous melanoma: available therapy for metastatic disease.Improving T cell therapy for cancer.Genetic modification of T cells for immunotherapy.Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes.CD28z CARs and armored CARsChimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them.Development of CAR T cells designed to improve antitumor efficacy and safety.T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors.
P2860
Q24546258-E6D8E3B0-E0A3-42C5-B0DB-9D5354647643Q26741260-355F8130-587C-45E6-896D-B369E1046358Q33715925-7EDBAC06-D06D-4738-B566-F98044902993Q34020065-DC1058A8-FBB5-44C6-9077-DD6339A349A3Q34657652-127C6ED8-D35E-41CF-81C2-784D0A01911AQ34657676-4A610BDE-E528-4DE5-829C-FF22EBB1962CQ36190624-358925F9-EA59-4491-B782-B74A10BDBE7EQ36333963-2BC248D0-F5CC-47F3-8B53-1D3037357987Q36365463-F5853129-8580-4F67-8613-8CDD94CFC27BQ36407236-430E7C17-05B5-436D-BF97-92AF973391E7Q36909362-A6BB77A8-9352-4345-9CC1-293DFBFA5B27Q37129943-90D7CD01-62C7-4132-8B88-C8E2E9E2E8AFQ37570109-6E10F427-C863-40EC-B108-292EE0F1CC45Q38199347-0E7A789E-81AF-4F01-851D-8ABE67A107A7Q38987239-DDE8BB81-B0E4-4911-9D7C-58E6BE7D82D2Q39200527-047EFFF5-E712-4E33-90EB-9544F62263E7Q45873576-843C2DFC-7D5A-4D91-81A6-3AE86C936D49Q50035774-5FA3991A-77D7-4626-B064-29C07C836D45
P2860
Interleukin-2-independent proliferation of human melanoma-reactive T lymphocytes transduced with an exogenous IL-2 gene is stimulation dependent
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Interleukin-2-independent prol ...... gene is stimulation dependent
@en
type
label
Interleukin-2-independent prol ...... gene is stimulation dependent
@en
prefLabel
Interleukin-2-independent prol ...... gene is stimulation dependent
@en
P2860
P1476
Interleukin-2-independent prol ...... gene is stimulation dependent
@en
P2093
Steven A Rosenberg
P2860
P304
P356
10.1097/00002371-200305000-00003
P577
2003-05-01T00:00:00Z